Patents Assigned to Voyager Pharmaceutical Corporation
  • METHODS FOR TREATING AND PREVENTING CANCERS THAT EXPRESS THE HYPOTHALAMIC-PITUITARY-GONADAL AXIS OF HORMONES AND RECEPTORS
    Publication number: 20110286998
    Abstract: Methods are provided for treating HPG axis-positive cancers, preventing or slowing proliferation of cells of HPG axis-positive cancer origin, preventing HPG axis-positive cancers in a patient at risk of contracting such cancers, preventing or inhibiting an upregulation of the cell cycle in HPG axis-positive cancer-derived cells in a patient, and decreasing the level of HPG axis-positive cancer-specific markers in a patient.
    Type: Application
    Filed: November 19, 2010
    Publication date: November 24, 2011
    Applicant: Voyager Pharmaceutical Corporation
    Inventors: Christopher W. Gregory, Maria E. Kononov, Eric S. Werdin, James Lester Barbee, IV, Carol Giamario
  • TREATMENT OF ALZHEIMER'S DISEASE AND MILD COGNITIVE IMPAIRMENT USING GNRH-I ANALOGS AND ONE OR MORE OF ACETYLCHOLINESTERASE INHIBITORS AND NMDA RECEPTOR ANTAGONISTS
    Publication number: 20110195898
    Abstract: Methods of treating, mitigating, slowing the progression of, or preventing Alzheimer's Disease and Mild Cognitive Impairment (MCI) include administration of gonadotropin-releasing hormone analogs in combination with acetylcholinesterase inhibitors and/or N-methyl-D-aspartate receptor antagonists.
    Type: Application
    Filed: August 30, 2010
    Publication date: August 11, 2011
    Applicant: Voyager Pharmaceutical Corporation
    Inventors: Christopher W. Gregory, Patrick S. Smith
  • METHODS FOR SLOWING SENESCENCE AND TREATING AND PREVENTING DISEASES ASSOCIATED WITH SENESCENCE
    Publication number: 20100267620
    Abstract: The present invention relates to a method for slowing, preventing or delaying senescence or treating or preventing a disease associated with senescence by administering a therapeutically effective amount of at least one physiological agent that decreases or regulates the blood level, production, function or activity of LH or FSH, or that decreases or regulates the production or activity of activin, or that increases or regulates the blood level, production, function, or activity of inhibin or follistatin.
    Type: Application
    Filed: March 22, 2010
    Publication date: October 21, 2010
    Applicant: Voyager Pharmaceutical Corporation
    Inventor: Richard L. Bowen
  • Methods for treating and preventing cancers that express the hypothalamic-pituitary-gonadal axis of hormones and receptors
    Publication number: 20090197796
    Abstract: Methods are provided for treating HPG axis-positive cancers, preventing or slowing proliferation of cells of HPG axis-positive cancer origin, preventing HPG axis-positive cancers in a patient at risk of contracting such cancers, preventing or inhibiting an upregulation of the cell cycle in HPG axis-positive cancer-derived cells in a patient, and decreasing the level of HPG axis-positive cancer-specific markers in a patient.
    Type: Application
    Filed: January 11, 2008
    Publication date: August 6, 2009
    Applicant: Voyager Pharmaceutical Corporation
    Inventors: Christopher W. Gregory, Maria E. Kononov, Eric S. Werdin, James Lester Barbee, IV, Carol Giamario
  • Leuprolide acetate and acetylcholinesterase inhibitors/NMDA receptor antagonists for the treatment of alzheimer's disease
    Publication number: 20080214639
    Abstract: Methods of treating, mitigating, slowing the progression of, or preventing Alzheimer's Disease include administration of gonadotropin-releasing hormone analogues in combination with acetylcholinesterase inhibitors and/or N-methyl-D-aspartate receptor antagonists.
    Type: Application
    Filed: August 8, 2007
    Publication date: September 4, 2008
    Applicant: Voyager Pharmaceutical Corporation
    Inventors: Christopher W. Gregory, Patrick S. Smith
  • Methods for treating prostate cancer
    Publication number: 20070238647
    Abstract: Methods are provided for treating prostate cancer, preventing or slowing proliferation of cells of prostate origin, preventing prostate cancer in a patient at risk of contracting prostate cancer, preventing or inhibiting an upregulation of the cell cycle in prostate-derived cells in a patient, and decreasing the level of prostate-specific antigen in a patient.
    Type: Application
    Filed: June 13, 2007
    Publication date: October 11, 2007
    Applicant: Voyager Pharmaceutical Corporation
    Inventors: Richard Bowen, Christopher Gregory
  • Methods for slowing senescence and treating and preventiing diseases associated with senescence
    Publication number: 20070173454
    Abstract: The present invention relates to a method for slowing, preventing or delaying senescence or treating or preventing a disease associated with senescence by administering a therapeutically effective amount of at least one physiological agent that decreases or regulates the blood level, production, function or activity of LH or FSH, or that decreases or regulates the production or activity of activin, or that increases or regulates the blood level, production, function, or activity of inhibin or follistatin.
    Type: Application
    Filed: February 23, 2007
    Publication date: July 26, 2007
    Applicant: Voyager Pharmaceutical Corporation
    Inventor: Richard Bowen
  • Methods for treating prostate cancer
    Publication number: 20070015713
    Abstract: Methods are provided for treating prostate cancer, preventing or slowing proliferation of cells of prostate origin, preventing prostate cancer in a patient at risk of contracting prostate cancer, preventing or inhibiting an upregulation of the cell cycle in prostate-derived cells in a patient, and decreasing the level of prostate-specific antigen in a patient.
    Type: Application
    Filed: July 14, 2005
    Publication date: January 18, 2007
    Applicant: Voyager Pharmaceutical Corporation
    Inventors: Richard Bowen, Christopher Gregory
  • Methods for treating and preventing cancers that express the hypothalamic-pituitary-gonadal axis of hormones and receptors
    Publication number: 20060234918
    Abstract: Methods are provided for treating HPG axis-positive cancers, preventing or slowing proliferation of cells of HPG axis-positive cancer origin, preventing HPG axis-positive cancers in a patient at risk of contracting such cancers, preventing or inhibiting an upregulation of the cell cycle in HPG axis-positive cancer-derived cells in a patient, and decreasing the level of HPG axis-positive cancer-specific markers in a patient.
    Type: Application
    Filed: March 22, 2006
    Publication date: October 19, 2006
    Applicant: Voyager Pharmaceutical Corporation
    Inventors: Christopher Gregory, Maria Kononov, Eric Werdin, James Barbee, Carol Giamario
  • Methods for treating and preventing brain cancers
    Publication number: 20060148697
    Abstract: Methods are provided for treating brain cancer, preventing or slowing proliferation of cells of prostate origin, preventing brain cancer in a patient at risk of contracting brain cancer, preventing or inhibiting an upregulation of the cell cycle in brain-derived cells in a patient, and decreasing the level of brain cancer-specific antigen in a patient.
    Type: Application
    Filed: July 14, 2005
    Publication date: July 6, 2006
    Applicant: Voyager Pharmaceutical Corporation
    Inventors: Richard Bowen, Christopher Gregory
  • Leuprolide acetate and acetylcholinesterase inhibitors or NMDA receptor antagonists for the treatment of alzheimer's disease
    Publication number: 20060142186
    Abstract: Methods of treating, mitigating, slowing the progression of, or preventing Alzheimer's Disease include administration of gonadotropin-releasing hormone analogues in combination with acetylcholinesterase inhibitors and/or N-methyl-D-aspartate receptor antagonists.
    Type: Application
    Filed: July 13, 2005
    Publication date: June 29, 2006
    Applicant: Voyager Pharmaceutical Corporation
    Inventors: Christopher Gregory, Patrick Smith
  • Methods for slowing senescence and treating and preventing diseases associated with senescence
    Publication number: 20030144203
    Abstract: The present invention relates to a method for slowing, preventing or delaying senescence or treating or preventing a disease associated with senescence by administering a therapeutically effective amount of at least one physiological agent that decreases or regulates the blood level, production, function or activity of LH or FSH, or that decreases or regulates the production or activity of activin, or that increases or regulates the blood level, production, function, or activity of inhibin or follistatin.
    Type: Application
    Filed: December 18, 2002
    Publication date: July 31, 2003
    Applicant: Voyager Pharmaceutical Corporation
    Inventor: Richard L. Bowen